# Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes

> **NCT05194592** · PHASE4 · UNKNOWN · sponsor: **Wonju Severance Christian Hospital** · enrollment: 122 (estimated)

## Conditions studied

- Type2 Diabetes
- Remodeling, Ventricular

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Gemigliptin

## Key facts

- **NCT ID:** NCT05194592
- **Lead sponsor:** Wonju Severance Christian Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-07
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05194592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05194592, "Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05194592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*